These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 9271024)

  • 41. The left and right ventricle of a patient with a R723G mutation of the beta-myosin heavy chain and severe hypertrophic cardiomyopathy show no differences in the expression of myosin mRNA.
    Borchert B; Tripathi S; Francino A; Navarro-Lopez F; Kraft T
    Cardiol J; 2010; 17(5):518-22. PubMed ID: 20865685
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Genotype-positive status in patients with hypertrophic cardiomyopathy is associated with higher rates of heart failure events.
    Li Q; Gruner C; Chan RH; Care M; Siminovitch K; Williams L; Woo A; Rakowski H
    Circ Cardiovasc Genet; 2014 Aug; 7(4):416-22. PubMed ID: 24909666
    [TBL] [Abstract][Full Text] [Related]  

  • 43. DNA testing in familial hypertrophic cardiomyopathy: clinical and laboratory implications.
    Smart RV; Yu B; Le H; French JA; Richmond DR; Jeremy RW; Semsarian C; Cheung L; Ross DA; Trent RJ
    Clin Genet; 1996 Oct; 50(4):169-75. PubMed ID: 9001794
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Genotype-phenotype correlations in familial hypertrophic cardiomyopathy].
    Anan R; Niimura H; Tei C
    Nihon Rinsho; 2000 Jan; 58(1):134-40. PubMed ID: 10885301
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Molecular basis of hypertrophic and dilated cardiomyopathy.
    Marian AJ; Roberts R
    Tex Heart Inst J; 1994; 21(1):6-15. PubMed ID: 8180512
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hypertrophic cardiomyopathy caused by a novel alpha-tropomyosin mutation (V95A) is associated with mild cardiac phenotype, abnormal calcium binding to troponin, abnormal myosin cycling, and poor prognosis.
    Karibe A; Tobacman LS; Strand J; Butters C; Back N; Bachinski LL; Arai AE; Ortiz A; Roberts R; Homsher E; Fananapazir L
    Circulation; 2001 Jan; 103(1):65-71. PubMed ID: 11136687
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hypertrophic obstructive cardiomyopathy due to a novel T-to-A transition at codon 624 in the beta-myosin heavy chain (beta-MHC) gene possibly related to the sudden death.
    Ohsuzu F; Katsushika S; Akanuma M; Nakamura H; Harada H; Satoh M; Hiroi S; Kimura A
    Int J Cardiol; 1997 Dec; 62(3):203-9. PubMed ID: 9476679
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Malignant mutations in hypertrophic cardiomyopathy: fact or fancy?
    Brito D; Madeira H
    Rev Port Cardiol; 2005 Sep; 24(9):1137-46. PubMed ID: 16335287
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy.
    Watkins H; Rosenzweig A; Hwang DS; Levi T; McKenna W; Seidman CE; Seidman JG
    N Engl J Med; 1992 Apr; 326(17):1108-14. PubMed ID: 1552912
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Familial hypertrophic cardiomyopathy.
    Piano MR
    J Cardiovasc Nurs; 1999 Jul; 13(4):46-58. PubMed ID: 10386271
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Hypertrophic cardiomyopathy: infrequent mutation of the cardiac beta-myosin heavy-chain gene].
    Mora R; Merino JL; Peinado R; Olias F; García-Guereta L; del Cerro MJ; Tarín MN; Molano J
    Rev Esp Cardiol; 2006 Aug; 59(8):846-9. PubMed ID: 16938236
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Familial hypertrophic cardiomyopathy associated with a novel missense mutation affecting the ATP-binding region of the cardiac beta-myosin heavy chain.
    Bundgaard H; Havndrup O; Andersen PS; Larsen LA; Brandt NJ; Vuust J; Kjeldsen K; Christiansen M
    J Mol Cell Cardiol; 1999 Apr; 31(4):745-50. PubMed ID: 10329202
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Evaluation of the risk of sudden death in hypertrophic cardiomyopathy].
    Sadoul N; de Chillou C; Aliot E; McKenna WJ
    Arch Mal Coeur Vaiss; 1999 Apr; 92 Spec No 1():65-73. PubMed ID: 10326160
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Structural effects of the slow/b-cardiac myosin heavy chain R453C mutation in cardiac and skeletal muscle.
    Tajsharghi H; Fyhr IM
    Scand Cardiovasc J; 2008 Apr; 42(2):153-6. PubMed ID: 18365899
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Genetic diagnosis of hypertrophic cardiomyopathy using mass spectrometry DNA arrays and high resolution melting.
    Santos S; Lança V; Oliveira H; Branco P; Silveira L; Marques V; Brito D; Madeira H; Bicho M; Fernandes AR
    Rev Port Cardiol; 2011 Jan; 30(1):7-18. PubMed ID: 21425739
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sudden death in mild hypertrophic cardiomyopathy with compound DSG2/DSC2/MYH6 mutations: Revisiting phenotype after genetic assessment in a master runner athlete.
    Castellana S; Mastroianno S; Palumbo P; Palumbo O; Biagini T; Leone MP; De Luca G; Potenza DR; Amico CM; Mazza T; Russo A; Di Stolfo G; Carella M
    J Electrocardiol; 2019; 53():95-99. PubMed ID: 30716529
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A new mutation of the cardiac troponin T gene causing familial hypertrophic cardiomyopathy without left ventricular hypertrophy.
    Varnava A; Baboonian C; Davison F; de Cruz L; Elliott PM; Davies MJ; McKenna WJ
    Heart; 1999 Nov; 82(5):621-4. PubMed ID: 10525521
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Preclinical diagnosis of familial hypertrophic cardiomyopathy by genetic analysis of blood lymphocytes.
    Rosenzweig A; Watkins H; Hwang DS; Miri M; McKenna W; Traill TA; Seidman JG; Seidman CE
    N Engl J Med; 1991 Dec; 325(25):1753-60. PubMed ID: 1944483
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Mutation analysis of beta myosin heavy chain gene in hypertrophic cardiomyopathy families].
    Fan XP; Yang ZW; Feng XL; Yang FH; Xiao B; Liang Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2011 Aug; 28(4):387-92. PubMed ID: 21811976
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical outcomes associated with sarcomere mutations in hypertrophic cardiomyopathy: a meta-analysis on 7675 individuals.
    Sedaghat-Hamedani F; Kayvanpour E; Tugrul OF; Lai A; Amr A; Haas J; Proctor T; Ehlermann P; Jensen K; Katus HA; Meder B
    Clin Res Cardiol; 2018 Jan; 107(1):30-41. PubMed ID: 28840316
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.